Neuracin Topical Gel

Neuracin Topical Analgesic Gel · METHYL SALICYLATE 300 mg/g; CAMPHOR (SYNTHETIC) 40 mg/g; MENTHOL, UNSPECIFIED FORM 100 mg/g · Gel · Topical · SOLA Pharmaceuticals

NDC 70512-0104-60 · 1 TUBE in 1 CARTON / 56.7 g in 1 TUBE · OTC MONOGRAPH DRUG · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Medicaid spend (2023)

$157,954

243 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Regulatory

Application: M017
TE code: —
Approval date: —
Patents / exclusivity: None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Neuracin Topical Analgesic Gel (Gel)

Labeler	Strength	First seen	Last seen
SOLA Pharmaceuticals	METHYL SALICYLATE 300 mg/g; CAMPHOR (SYNTHETIC) 40 mg/g; MENTHOL, UNSPECIFIED FORM 100 mg/g	Aug 26, 2026	Sep 2, 2026
SOLA Pharmaceuticals	METHYL SALICYLATE 40 mg/g; CAMPHOR (SYNTHETIC) 100 mg/g; MENTHOL, UNSPECIFIED FORM 300 mg/g	Jul 22, 2026	Aug 19, 2026
SOLA Pharmaceuticals	CAMPHOR (SYNTHETIC) 40 mg/g; MENTHOL, UNSPECIFIED FORM 100 mg/g; METHYL SALICYLATE 300 mg/g	Jul 15, 2026	Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Neuracin Topical Gel — NDC 70512-0104-60," retrieved September 3, 2026, https://drugdashboards.com/drug/70512010460.

Free to cite with attribution — see how the data is put together.